Daily Bulletin (17th March, 2022)

Daily Bulletin (17th March, 2022)



Scrip code : 533096

Name : Adani Power Limited

Subject : Intimation In Respect Of Completion Of Acquisition Of Essar Power M P Limited

Disclosure under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 – Completion of acquisition of Essar Power M P Limited.


Scrip code : 500477

Name : Ashok Leyland Ltd.,

Subject : Announcement under Regulation 30 (LODR)-Allotment

In furtherance to our letter dated February 11, 2022 and pursuant to Regulation 30 and other applicable provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Fund Raising Committee of the Board of Directors of the Company on March 17, 2022, has allotted 2,000 (Two Thousand) Secured, Listed, Rated, Redeemable, Non-Cumulative, Non-Convertible Debentures (‘NCDs’) having face value of Rs. 10,00,000/- (Rupees Ten Lakhs only) each for cash aggregating to Rs. 200,00,00,000/- (Rupees Two Hundred Crores only) on private placement basis. The said NCDs will be listed on the Wholesale Debt Market segment of the National Stock Exchange of India Limited. The details required in terms of Para A of Part A of Schedule III of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 is enclosed as Annexure.


Scrip code : 500027

Name : Atul Limited.,

Subject : Board to consider Buy back of Equity Shares

Atul Ltd has informed BSE that the meeting of the Board of Directors of the Company will be held on March 25, 2022, inter alia, to consider a proposal for Buy-back of Equity Shares of face value of Rs. 10/- each of the Company. Further, in terms of the Company’s Code of Conduct for Prohibition of Insider Trading, the trading window for dealing in securities of the Company will remain closed from March 18, 2022 to March 27, 2022 (both days inclusive).


Scrip code : 524804

Name : Aurobindo Pharma Ltd.

Subject : Announcement under Regulation 30 (LODR)-Press Release / Media Release

We enclose a copy of the Press Release that is being issued by the Company, announcing that the Company along with its subsidiaries is signing of sub-license agreement for a generic version of Pfizer”s Covid19 oral treatment nirmatrelvir with the UN backed Medicines Patent Pool (MPP), headquartered in Geneva, for manufacturing and supplying the generic drug product to 95 countries including India.


Scrip code : 511589

Name : Avonmore Capital & Management Services Limited

Subject : Sale Of Investment Held In Wholly Owned Subsidiary Company Namely ‘Anemone Holdings Private Limited.’

Pursuant To The Approval Of Insurance Regulatory And Development Authority Of India (‘IRDA’) Dear Sir/Ma’am, This is in reference to the subject matter mentioned above and in continuation of our earlier intimation to the Exchange vide letter Ref No. acms/corres/Bse/21-22/0039 dated October 27, 2021, we wish to inform you that, Insurance Regulatory and Development Authority of India (‘IRDA’) vide their letter dated 16.03.2022 has approved the proposed Sale/Transfer of the entire 26% holding consisting of 14,04,000 equity shares in Willis Towers Watson India Insurance Brokers Pvt. Ltd., which is presently held by our wholly owned subsidiary namely, Anemone Holdings Private Limited. We will keep you updated in the matter. We request you to take the above on record and the same be treated as compliance under the applicable provisions of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended. You are requested to kindly take the same on your record.


Scrip code : 512068

Name : Deccan Gold Mines Ltd.

Subject : Entering Into A Non-Binding Mou With Tally Ltd With Regard To Acquire Its Stake In Finland Gold Projects Entering into a non-binding MoU with Tally Ltd with regard to acquire its stake in Finland Gold Projects.


Scrip code : 535789


Subject : Allotment Of Equity Shares Pursuant To Conversion Of USD 10,000,000 4.50 Per Cent. Secured Convertible Bonds Due 2026 (‘Fccbs’) Into Equity Shares

Pursuant to the applicable provisions of SEBI (LODR) Regulations, 2015, we wish to inform that consequent upon the conversion of FCCBs, allotted on September 28, 2021 under ISIN XS2377720839 for an aggregate USD 165,000,000 4.50 per cent., in terms of the offering circular dated September 21, 2021 and pursuant to receipt of notice for conversion of FCCBs, for a principle value USD 10,000,000 the Company, has today issued and allotted 30,25,126 Fully Paid Equity shares of face value INR 2/- each, at a conversion price of INR 243.05 (including a premium of INR 241.05) per Equity Share, to the holder of such FCCBs. Consequent to the said allotment, the paid-up Equity Share Capital of the Company stands increased to INR 93,71,43,008 divided into 46,85,71,504 Fully Paid Equity Shares and outstanding principal value of FCCBs, as listed at SGX issued under ISIN XXS2301133943 is USD 149,500,000 and FCCBs issued under ISIN XS2377720839, stands reduced from USD 155,000,000 to USD 145,000,000.


Scrip code : 534309

Name : NBCC (India) Limited

Subject : Intimation Of Award Of Work By NBCC (India) Limited

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform that NBCC (India) Limited has awarded the work for Construction of 768 Units (3BHK) Social Housing Units in Hulhumale, Republic of Maldives (Pkg-II) to M/s Varindera Constructions Limited for a total contract value of USD 42,960,000/-. The aforesaid information is also available on the website of the Company at http://www.nbccindia.com/webEnglish/announcementNotices.aspx.